93 related articles for article (PubMed ID: 8135625)
1. Varying grades of epithelial atypia in the pancreatic ducts of humans. Classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen.
Furukawa T; Chiba R; Kobari M; Matsuno S; Nagura H; Takahashi T
Arch Pathol Lab Med; 1994 Mar; 118(3):227-34. PubMed ID: 8135625
[TBL] [Abstract][Full Text] [Related]
2. Proposal for the classification of epithelial atypism of pancreatic duct lesions.
Kimura W
Hepatogastroenterology; 2007; 54(79):2155-8. PubMed ID: 18251180
[TBL] [Abstract][Full Text] [Related]
3. HER-2/Neu expression as a progression marker in pancreatic intraepithelial neoplasia.
Tomaszewska R; Okoń K; Nowak K; Stachura J
Pol J Pathol; 1998; 49(2):83-92. PubMed ID: 9798411
[TBL] [Abstract][Full Text] [Related]
4. [Histomorphometric study of normal, atypical and neoplastic pancreatic duct epithelium].
von Streitberg U
Verh Dtsch Ges Pathol; 1990; 74():207-10. PubMed ID: 1708585
[TBL] [Abstract][Full Text] [Related]
5. Immuno-histochemical investigations with monoclonal antibodies against CEA-related components in chronic pancreatitis and pancreatic carcinoma.
Makovitzky J
Hepatogastroenterology; 1987 Feb; 34(1):31-5. PubMed ID: 2437000
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components.
Sanada Y; Yoshida K; Ohara M; Oeda M; Konishi K; Tsutani Y
Pancreas; 2006 Mar; 32(2):164-70. PubMed ID: 16552336
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional structure of the rat pancreatic duct in normal and inflammated pancreas.
Ashizawa N; Endoh H; Hidaka K; Watanabe M; Fukumoto S
Microsc Res Tech; 1997 Jun 1-15; 37(5-6):543-56. PubMed ID: 9220430
[TBL] [Abstract][Full Text] [Related]
8. Endocrine and intermediate cells in pancreatic ductal carcinoma and in chronic pancreatitis.
Szynaka B; Zimnoch L; Puchalski Z; Szynaka P
Rocz Akad Med Bialymst; 2002; 47():21-30. PubMed ID: 12533945
[TBL] [Abstract][Full Text] [Related]
9. AgNORs in duct epithelial lesions in chronic pancreatitis and in pancreas cancer cells.
Cylwik B; Nowak HF; Puchalski Z; Zimnoch L; Dadan J
Hepatogastroenterology; 1998; 45(22):1130-4. PubMed ID: 9756019
[TBL] [Abstract][Full Text] [Related]
10. Bile-reflux into the pancreatic ducts is associated with the development of intraductal papillary carcinoma in hamsters.
Adachi T; Tajima Y; Kuroki T; Mishima T; Kitasato A; Fukuda K; Tsutsumi R; Kanematsu T
J Surg Res; 2006 Nov; 136(1):106-11. PubMed ID: 16863651
[TBL] [Abstract][Full Text] [Related]
11. Where and when does pancreatic carcinoma start?
Lüttges J; Hahn S; Klöppel G
Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal instability in pancreatic ductal cells from patients with chronic pancreatitis and pancreatic adenocarcinoma.
Moskovitz AH; Linford NJ; Brentnall TA; Bronner MP; Storer BE; Potter JD; Bell RH; Rabinovitch PS
Genes Chromosomes Cancer; 2003 Jun; 37(2):201-6. PubMed ID: 12696069
[TBL] [Abstract][Full Text] [Related]
13. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
14. Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas: an immunohistochemical study.
Terada T; Ohta T; Kitamura Y; Ashida K; Matsunaga Y
Arch Pathol Lab Med; 1998 Jan; 122(1):42-6. PubMed ID: 9448015
[TBL] [Abstract][Full Text] [Related]
15. Proliferative activity in pancreatic intraepithelial neoplasias of chronic pancreatitis resection specimens: detection of a high-risk lesion.
Hermanová M; Nenutil R; Kren L; Feit J; Pavlovský Z; Díte P
Neoplasma; 2004; 51(5):400-4. PubMed ID: 15640947
[TBL] [Abstract][Full Text] [Related]
16. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
Soldini D; Gugger M; Burckhardt E; Kappeler A; Laissue JA; Mazzucchelli L
J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms.
Adsay NV; Longnecker DS; Klimstra DS
Semin Diagn Pathol; 2000 Feb; 17(1):16-30. PubMed ID: 10721804
[TBL] [Abstract][Full Text] [Related]
18. [The grading of cellular and structural atypia in cancer and related lesions using multivariate analysis].
Chiba R; Furukawa T; Nakamura M; Mori M; Tezuka F; Takahashi T
Nihon Rinsho; 1992 Oct; 50(10):2515-24. PubMed ID: 1447825
[TBL] [Abstract][Full Text] [Related]
19. The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation.
Lüttges J; Schemm S; Vogel I; Hedderich J; Kremer B; Klöppel G
J Pathol; 2000 Jun; 191(2):154-61. PubMed ID: 10861575
[TBL] [Abstract][Full Text] [Related]
20. How many millimeters do atypical epithelia of the pancreas spread intraductally before beginning to infiltrate?
Kimura W
Hepatogastroenterology; 2003; 50(54):2218-24. PubMed ID: 14696502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
